Related Experiment Video
Updated: Jan 19, 2026

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Published on: October 20, 2018
Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and
Chikara Iino1, Tetsu Endo2, Kenichiro Mikami3
1Department of Gastroenterology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan. chikaran0601@yahoo.co.jp.
Nonalcoholic fatty liver disease (NAFLD) is associated with altered gut microbiota. This study found a significant decrease in Faecalibacterium in NAFLD patients, even after matching for BMI and sex, suggesting its role in NAFLD development.
Area of Science:
- Gastroenterology and Hepatology
- Microbiome Research
- Metabolic Disease Research
Background:
- Gut microbiota alterations are observed in nonalcoholic fatty liver disease (NAFLD), but findings vary across studies.
- Previous research has not consistently isolated the impact of obesity and sex on these gut microbial changes.
- This study addresses these inconsistencies by examining gut microbiota in NAFLD patients while controlling for BMI and sex.
Purpose of the Study:
- To investigate gut microbiota composition differences between NAFLD and non-NAFLD individuals.
- To specifically evaluate the role of gut bacteria, excluding confounding factors like obesity and sex.
- To identify specific bacterial taxa associated with NAFLD pathogenesis.
Main Methods:
- A large cohort of 1148 adults was surveyed.
- NAFLD was diagnosed via ultrasonography, excluding other causes of fatty liver.
- Participants were matched for Body Mass Index (BMI) and sex to isolate microbiota differences.
Main Results:
- 205 participants (23.5%) had NAFLD.
- After BMI and sex matching (153 pairs), a significant decrease in Ruminococcaceae and Faecalibacterium was observed in NAFLD patients.
- The reduction in Faecalibacterium abundance was statistically significant (p=0.018).
Conclusions:
- A notable decrease in Faecalibacterium is a key finding in NAFLD patients, independent of BMI and sex.
- This reduction in Faecalibacterium is linked to the development and progression of NAFLD.
- Targeting Faecalibacterium may offer therapeutic potential for NAFLD.
More Related Videos
06:23Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
Published on: February 15, 2019
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
Related Concept Videos
14:54An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
06:23Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
04:09An Ex Vivo Gut Organ Culture System to Study Host-Microbiota Interactions
07:54A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice